Alzheimer's disease (AD) patients tend to have increased plasma levels of homocysteine.
However, it is unclear whether abnormality in homocysteine levels is a primary cause of …

Recent epidemiological and clinical data suggest that elevated serum homocysteine levels
may increase the risk of developing Alzheimer's disease (AD), but the underlying …

Observational studies have consistently reported elevated plasma homocysteine as a risk
factor for Alzheimer's disease (AD). However, results from clinical trials of homocysteine …

Objective: To explore the association between high homocysteine levels and risk of
Alzheimer disease (AD) in the Washington Heights-Inwood Columbia Aging Project …

Background: Identifying modifiable risk factors for cognitive decline can reduce burden of
dementia. Objective: We examined whether homocysteine was associated with memory …

Dementia is a common and devastating public health problem, affecting an estimated
5±10% of individuals over the age of 65 [1]. Two pathologically distinct subtypes of …

Background In cross-sectional studies, elevated plasma homocysteine levels have been
associated with poor cognition and dementia. Studies of newly diagnosed dementia are …

Background Elevated plasma homocysteine and amyloid β (Aβ) have been associated with
Alzheimer's disease (AD). We investigated the cross-sectional association between these …

Patients with Alzheimer's disease have higher plasma homocysteine levels than controls,
but it is uncertain whether higher plasma homocysteine levels are involved in the early …

Objective Moderately elevated levels of plasma total homocysteine are associated with an
increased risk of developing Alzheimer's disease. We have tested whether baseline …